A citation-based method for searching scientific literature

Carmen F A Eustatia-Rutten, Eleonora P M Corssmit, Nienke R Biermasz, Alberto M Pereira, Johannes A Romijn, Johannes W Smit. J Clin Endocrinol Metab 2006
Times Cited: 196







List of co-cited articles
612 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.
C Durante, N Haddy, E Baudin, S Leboulleux, D Hartl, J P Travagli, B Caillou, M Ricard, J D Lumbroso, F De Vathaire,[...]. J Clin Endocrinol Metab 2006
932
31

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
30

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
David S Cooper, Gerard M Doherty, Bryan R Haugen, Richard T Kloos, Stephanie L Lee, Susan J Mandel, Ernest L Mazzaferri, Bryan McIver, Furio Pacini, Martin Schlumberger,[...]. Thyroid 2009
22


Thyroid carcinoma.
Steven I Sherman. Lancet 2003
754
15

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
Marcia S Brose, Christopher M Nutting, Barbara Jarzab, Rossella Elisei, Salvatore Siena, Lars Bastholt, Christelle de la Fouchardiere, Furio Pacini, Ralf Paschke, Young Kee Shong,[...]. Lancet 2014
858
14



Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Martin Schlumberger, Makoto Tahara, Lori J Wirth, Bruce Robinson, Marcia S Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H Shah, Ana O Hoff,[...]. N Engl J Med 2015
974
12

Papillary and follicular thyroid carcinoma.
M J Schlumberger. N Engl J Med 1998
11

Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors.
Gabriella Pellegriti, Francesco Frasca, Concetto Regalbuto, Sebastiano Squatrito, Riccardo Vigneri. J Cancer Epidemiol 2013
719
11




Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.
Alan L Ho, Ravinder K Grewal, Rebecca Leboeuf, Eric J Sherman, David G Pfister, Desiree Deandreis, Keith S Pentlow, Pat B Zanzonico, Sofia Haque, Somali Gavane,[...]. N Engl J Med 2013
475
9

Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
Tetsuo Kondo, Shereen Ezzat, Sylvia L Asa. Nat Rev Cancer 2006
650
9



European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.
Furio Pacini, Martin Schlumberger, Henning Dralle, Rossella Elisei, Johannes W A Smit, Wilmar Wiersinga. Eur J Endocrinol 2006
9


Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.
Julio C Ricarte-Filho, Mabel Ryder, Dhananjay A Chitale, Michael Rivera, Adriana Heguy, Marc Ladanyi, Manickam Janakiraman, David Solit, Jeffrey A Knauf, R Michael Tuttle,[...]. Cancer Res 2009
370
8

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli,[...]. J Clin Oncol 2012
865
8


Phase II trial of sorafenib in metastatic thyroid cancer.
Richard T Kloos, Matthew D Ringel, Michael V Knopp, Nathan C Hall, Mark King, Robert Stevens, Jiachao Liang, Paul E Wakely, Vasyl V Vasko, Motoyasu Saji,[...]. J Clin Oncol 2009
403
7

Cabozantinib in progressive medullary thyroid cancer.
Rossella Elisei, Martin J Schlumberger, Stefan P Müller, Patrick Schöffski, Marcia S Brose, Manisha H Shah, Lisa Licitra, Barbara Jarzab, Viktor Medvedev, Michael C Kreissl,[...]. J Clin Oncol 2013
673
7

Molecular genetics and diagnosis of thyroid cancer.
Yuri E Nikiforov, Marina N Nikiforova. Nat Rev Endocrinol 2011
611
7


Guidelines for the management of thyroid cancer.
Petros Perros, Kristien Boelaert, Steve Colley, Carol Evans, Rhordi M Evans, Georgina Gerrard Ba, Jackie Gilbert, Barney Harrison, Sarah J Johnson, Thomas E Giles,[...]. Clin Endocrinol (Oxf) 2014
645
7

Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.
Zhi Liu, Peng Hou, Meiju Ji, Haixia Guan, Kimberly Studeman, Kirk Jensen, Vasily Vasko, Adel K El-Naggar, Mingzhao Xing. J Clin Endocrinol Metab 2008
286
6

Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial.
Sophie Leboulleux, Lars Bastholt, Thomas Krause, Christelle de la Fouchardiere, Jan Tennvall, Ahmad Awada, José Manuel Gómez, Françoise Bonichon, Laurence Leenhardt, Christine Soufflet,[...]. Lancet Oncol 2012
244
6

Phase II trial of sorafenib in advanced thyroid cancer.
Vandana Gupta-Abramson, Andrea B Troxel, Anoma Nellore, Kanchan Puttaswamy, Maryann Redlinger, Kathy Ransone, Susan J Mandel, Keith T Flaherty, Laurie A Loevner, Peter J O'Dwyer,[...]. J Clin Oncol 2008
499
6

Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.
Laurie L Carr, David A Mankoff, Bernardo H Goulart, Keith D Eaton, Peter T Capell, Elizabeth M Kell, Julie E Bauman, Renato G Martins. Clin Cancer Res 2010
286
6

New therapeutic approaches for metastatic thyroid carcinoma.
Eric Baudin, Martin Schlumberger. Lancet Oncol 2007
111
6

Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases.
Y Kitamura, K Shimizu, M Nagahama, K Sugino, O Ozaki, T Mimura, K Ito, K Ito, S Tanaka. J Clin Endocrinol Metab 1999
166
6


Guidelines for radioiodine therapy of differentiated thyroid cancer.
M Luster, S E Clarke, M Dietlein, M Lassmann, P Lind, W J G Oyen, J Tennvall, E Bombardieri. Eur J Nucl Med Mol Imaging 2008
406
6

Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis.
T P Links, K M van Tol, P L Jager, J Th M Plukker, D A Piers, H M Boezen, R P F Dullaart, E G E de Vries, W J Sluiter. Endocr Relat Cancer 2005
97
6

Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients.
Maria Grazia Castagna, Fabio Maino, Claudia Cipri, Valentina Belardini, Alexandra Theodoropoulou, Gabriele Cevenini, Furio Pacini. Eur J Endocrinol 2011
176
6

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.
Mingzhao Xing, William H Westra, Ralph P Tufano, Yoram Cohen, Eli Rosenbaum, Kerry J Rhoden, Kathryn A Carson, Vasily Vasko, Alexandr Larin, Giovanni Tallini,[...]. J Clin Endocrinol Metab 2005
721
6

Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning.
Richard J Robbins, Qiang Wan, Ravinder K Grewal, Roland Reibke, Mithat Gonen, H William Strauss, R Michael Tuttle, William Drucker, Steven M Larson. J Clin Endocrinol Metab 2006
358
6

Current thyroid cancer trends in the United States.
Louise Davies, H Gilbert Welch. JAMA Otolaryngol Head Neck Surg 2014
987
6


Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
Brian Hung-Hin Lang, Chung-Yau Lo, Wai-Fan Chan, King-Yin Lam, Koon-Yat Wan. Ann Surg Oncol 2007
100
5

Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.
Peng Hou, Dingxie Liu, Yuan Shan, Shuiying Hu, Kimberley Studeman, Stephen Condouris, Yangang Wang, Ariel Trink, Adel K El-Naggar, Giovanni Tallini,[...]. Clin Cancer Res 2007
287
5

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
5

Approach to the patient with advanced differentiated thyroid cancer.
M Schlumberger, S I Sherman. Eur J Endocrinol 2012
92
5

Outcomes of patients with differentiated thyroid carcinoma following initial therapy.
Jacqueline Jonklaas, Nicholas J Sarlis, Danielle Litofsky, Kenneth B Ain, S Thomas Bigos, James D Brierley, David S Cooper, Bryan R Haugen, Paul W Ladenson, James Magner,[...]. Thyroid 2006
440
5

A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome.
Anna Guerra, Laura Fugazzola, Vincenzo Marotta, Massimo Cirillo, Stefania Rossi, Valentina Cirello, Irene Forno, Tania Moccia, Alfredo Budillon, Mario Vitale. J Clin Endocrinol Metab 2012
103
5

Staging systems for papillary thyroid carcinoma: a review and comparison.
Brian Hung-Hin Lang, Chung-Yau Lo, Wai-Fan Chan, King-Yin Lam, Koon-Yat Wan. Ann Surg 2007
172
5

A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group.
D P Byar, S B Green, P Dor, E D Williams, J Colon, H A van Gilse, M Mayer, R J Sylvester, M van Glabbeke. Eur J Cancer 1979
496
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.